Back
First Virtual Cells - Genetic Engineering & Biotechnology News
webliebertpub.com·liebertpub.com/doi/full/10.1089/genbio.2025.0007
This article is tangentially relevant to AI safety as it illustrates rapidly advancing AI-biology capabilities; relevant for those tracking dual-use biotechnology risks and the role of AI in accelerating biological science.
Metadata
Importance: 28/100journal articlenews
Summary
This article discusses advances toward creating 'virtual cells' — comprehensive computational models that simulate the full behavior of biological cells at a molecular level. It covers the scientific and technical milestones enabling such simulations and their implications for biotechnology, drug discovery, and synthetic biology.
Key Points
- •Virtual cells aim to computationally replicate all biological processes within a living cell, integrating genomics, proteomics, and metabolomics data.
- •AI and machine learning play a central role in enabling the complexity of whole-cell modeling by predicting molecular interactions and dynamics.
- •Such models could accelerate drug discovery, metabolic engineering, and our understanding of disease mechanisms.
- •The work represents a convergence of systems biology, synthetic biology, and AI-driven simulation.
- •Ethical and biosecurity considerations arise as virtual cells could eventually guide design of novel organisms or synthetic life.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Chan Zuckerberg Initiative | Organization | 50.0 |
Cached Content Preview
HTTP 200Fetched Mar 20, 20260 KB
[Back to Top](https://www.liebertpub.com/action/cookieAbsent#) [iframe](https://mal.scienceconnect.io/teaser.html)
Resource ID:
dcba74c27f2dd75a | Stable ID: MzY5YTRhYj